癌症治愈能力的进化决定因素
Marcela Braga Mansur1, Nandita M deSouza2,3, Rachael Natrajan4
1Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
Nature ecology & evolution
|August 24, 2023
概括
成年癌症的耐药性通常涉及TP53基因突变,阻碍治愈. 可治愈的罕见癌症,通常是TP53野生类型,为克服这一挑战提供了洞察力.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 进化医学是一种进化医学.
背景情况:
- 成年癌症的耐药性是治疗治疗的主要障碍,经常与TP53基因突变有关.
- 相反,罕见的TP53野生型恶性瘤的治愈率很高,这表明TP53状态对癌症治愈能力至关重要.
研究的目的:
- 通过将常见的成人癌症与可治愈的罕见恶性瘤进行比较,探索导致耐药性的进化和发育因素.
- 了解TP53基因功能如何影响癌细胞进化,耐药性和整体治疗结果.
主要方法:
- 可治愈癌症与耐药癌症的遗传和表型特征的比较分析.
- 审查TP53蛋白功能在选择性压力下癌细胞存活,适应和进化的作用.
- 检查癌细胞的发育起源及其对药物敏感性的影响.
主要成果:
- 获得的TP53蛋白功能的丧失是癌症中常见的事件,赋予了生存优势并促进了进化性.
- TP53-null细胞表现出对亡的抵抗力,耐受DNA损伤,并具有增强的自我更新能力,促进对治疗的适应.
- 来自胚胎/胎儿细胞的可治愈癌症,由于不同的发育和遗传特征,保留TP53依赖的亡和药物过敏性.
结论:
- TP53损失是药物耐药性和常见成人癌症预后不佳的关键驱动因素.
- 癌细胞的发育起源和内在的遗传构成显著影响它们对疗法的敏感性.
- 了解这些决定因素可能为针对药物耐药性机制的新型治疗策略铺平道路.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:18Cancer
48.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:59Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K